protein_complex

Inflammasome Complex

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Inflammasome Complex: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
15Hypotheses
0Analyses
2Outgoing
1Incoming
4Experiments
0Debates

Summary

A multi-protein complex that activates caspase-1-mediated inflammatory responses. The NLRP3 inflammasome is the best-characterized, consisting of NLRP3 sensor, ASC adaptor (PYCARD), and pro-caspase-1. Assembly triggers IL-1β and IL-18 maturation and pyroptotic cell death. NLRP3 inflammasome activation is driven by amyloid-β, α-synuclein, and tau aggregates in neurodegenerative diseases.

Ontology: GO:0061702 · MESH:D000077192

No AI portrait yet

Mechanism Info
NameNLRP3_INFLAMMASOME
Key Genes/ProteinsIL18, IL1B, TREM2

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

NLRP3 Inflammasome

entity · 1114 words

Outgoing (2)

TargetRelationTypeStr
IL1Bproducesprotein0.64
IL18producesprotein0.64

Incoming (1)

SourceRelationTypeStr
TREM2inhibitsprotein0.72

Targeting Hypotheses (15)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S 0.822 neurodegeneration What are the mechanisms by which gut mic
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In 0.720 neurodegeneration What molecular mechanisms drive microgli
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha 0.631 neuroinflammation What are the specific molecular mechanis
Galectin-3 deletion attenuates NLRP3 inflammasome activation 0.625 neuroscience Lysosomal dysfunction and cathepsin leak
NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosi 0.620 neurodegeneration How does gut microbiome dysbiosis contri
Selective cathepsin B inhibition prevents cathepsin leakage- 0.620 neuroscience Lysosomal dysfunction and cathepsin leak
Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP 0.590 neurodegeneration What are the optimal oxygen pressure, du
NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumul 0.566 developmental neurobiology Do perinatal immune challenges create pe
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev 0.566 neurodegeneration Why have numerous phase 3 clinical trial
P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming 0.563 biomarkers What biomarkers can reliably detect micr
TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inf 0.485 Neuroinflammation Immune atlas neuroinflammation analysis
Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X 0.465 - What is the minimum effective dose of tr
NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib 0.105 neurodegeneration Neuroinflammation Biomarker Panel for Ea
STING-Mediated NLRP3 Inflammasome Priming in ALS Microglia 0.000 Neuroinflammation Immune atlas neuroinflammation analysis
Circulating hs-CRP as Disease-Modifying Target via Astrocyti 0.000 immunomics Systemic immune profiling in neurodegene

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (4)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Molecular characterization of RBG-NLRP3 binding interaction exploratory atherosclerosis 0.900 0.00 purified proteins and molecula proposed N/A
Leukocyte gene expression analysis in COVID-19 patients exploratory COVID-19 0.900 0.00 human leukocytes from COVID-19 proposed N/A
RBG effects on macrophage polarization and foam cell formation exploratory atherosclerosis 0.850 0.00 primary macrophages proposed N/A
Transcriptomic analysis of RBG effects on inflammatory gene expression exploratory atherosclerosis 0.800 0.00 ApoE-/- mice and cell cultures proposed N/A

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] Hegdekar N, Sarkar C, Bustos S, Ritzel R Autophagy 2023 0
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500] Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Aging cell 2023 0
Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like [PMID:36288697] Li S, Fang Y, Zhang Y, Song M, Zhang X, Cell reports 2022 0
Biomarker of Neuroinflammation in Parkinson's Disease. [PMID:35456966] Liu TW, Chen CM, Chang KH Int J Mol Sci 2022 0
NLRP3 inflammasome activation drives tau pathology. [PMID:31748742] ["Ising C", "Venegas C", "Zhang S", "Sch Nature 2019 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Inflammasome Complex in their description or question text

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP3 inflammasome and s

Score: 0.590 · neurodegeneration · 2026-04-25

This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti

NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation

Score: 0.566 · developmental neurobiology · 2026-04-21

## Mechanistic Overview NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation starts from the claim that mod

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming

Score: 0.563 · biomarkers · 2026-04-22

## Mechanistic Overview P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming starts from the claim that modulatin

TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation

Score: 0.485 · Neuroinflammation · 2026-04-21

## Mechanistic Overview TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation starts from the

Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X7 Receptor Blockade

Score: 0.465 · unknown disease · 2026-04-26

Trazodone acts as a weak antagonist at P2X7 purinergic receptors (IC50 ~3 micromolar), suppressing microglial NLRP3 infl

NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhibition

Score: 0.105 · neurodegeneration · 2026-04-18

## Mechanistic Overview NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhibition starts from the claim that mod

STING-Mediated NLRP3 Inflammasome Priming in ALS Microglia

Score: 0.000 · Neuroinflammation · 2026-04-26

This hypothesis proposes that cytoplasmic mtDNA released from TDP-43-damaged mitochondria in ALS activates the cGAS-STIN

Circulating hs-CRP as Disease-Modifying Target via Astrocytic NLRP3 Inflammasome

Score: 0.000 · immunomics · 2026-04-27

Elevated circulating high-sensitivity C-reactive protein (hs-CRP) serves as a disease-modifying target through direct ac